FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296396617> ?p ?o ?g. }

• W4296396617 abstract "Cutaneous squamous cell carcinoma (cSCC) is a frequent skin cancer with a high risk of recurrence characterized by tumor infiltration and, in advanced cases, a poor prognosis. ECT (electrochemotherapy) is an alternative treatment option for locally advanced or recurrent cSCC that is unsuitable for surgical resection. In this study, we aimed to evaluate the data in the InspECT (International Network for Sharing Practice on ECT) registry of the referral centers and to clarify the indications for the use of ECT as a treatment modality for cSCC.Patients with primary, recurrent or locally advanced cSCC from 18 European centers were included. They underwent at least one ECT session with bleomycin between February 2008 and November 2020, which was performed following the European Standard Operating Procedures.The analysis included 162 patients (mean age of 80 years; median, 1 lesion/patient). Side effects were mainly local and mild (hyperpigmentation, 11%; ulceration, 11%; suppuration, 4%). The response to treatment per patient was 62% complete and 21% partial. In the multivariate model, intravenous drug administration and small tumor size showed a significant association with a positive outcome (objective response). One-year local progression-free survival was significantly better (p<0.001) in patients with primary tumors (80% (95% C.I. 70%-90%) than in patients with locally advanced disease (49% (95% C.I. 30%-68%).In the present study, ECT showed antitumor activity and a favorable safety profile in patients with complex cSCC for whom there was no widely accepted standard of care. Better results were obtained in primary and small tumors (<3 cm) using intravenous bleomycin administration." @default.
• W4296396617 created "2022-09-20" @default.
• W4296396617 creator A5015691544 @default.
• W4296396617 creator A5025699073 @default.
• W4296396617 creator A5026173634 @default.
• W4296396617 creator A5026368285 @default.
• W4296396617 creator A5038197610 @default.
• W4296396617 creator A5040733348 @default.
• W4296396617 creator A5041857612 @default.
• W4296396617 creator A5046606681 @default.
• W4296396617 creator A5050982520 @default.
• W4296396617 creator A5052470134 @default.
• W4296396617 creator A5054961792 @default.
• W4296396617 creator A5056415273 @default.
• W4296396617 creator A5056603443 @default.
• W4296396617 creator A5057389049 @default.
• W4296396617 creator A5059661948 @default.
• W4296396617 creator A5064240367 @default.
• W4296396617 creator A5066790760 @default.
• W4296396617 creator A5068946724 @default.
• W4296396617 creator A5074341433 @default.
• W4296396617 creator A5076500054 @default.
• W4296396617 creator A5077643980 @default.
• W4296396617 creator A5081959980 @default.
• W4296396617 creator A5082347133 @default.
• W4296396617 creator A5085501918 @default.
• W4296396617 creator A5088700252 @default.
• W4296396617 creator A5089972709 @default.
• W4296396617 date "2022-09-20" @default.
• W4296396617 modified "2023-10-16" @default.
• W4296396617 title "Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020)" @default.
• W4296396617 cites W1104841088 @default.
• W4296396617 cites W1732540979 @default.
• W4296396617 cites W2005064613 @default.
• W4296396617 cites W2019607817 @default.
• W4296396617 cites W2161148136 @default.
• W4296396617 cites W2162071711 @default.
• W4296396617 cites W2273048750 @default.
• W4296396617 cites W2412507794 @default.
• W4296396617 cites W2472135287 @default.
• W4296396617 cites W2555652867 @default.
• W4296396617 cites W2559433559 @default.
• W4296396617 cites W2580064732 @default.
• W4296396617 cites W2609929688 @default.
• W4296396617 cites W2739253962 @default.
• W4296396617 cites W2782712404 @default.
• W4296396617 cites W2790771749 @default.
• W4296396617 cites W2793453599 @default.
• W4296396617 cites W2795330540 @default.
• W4296396617 cites W2805968856 @default.
• W4296396617 cites W2896463789 @default.
• W4296396617 cites W2904720823 @default.
• W4296396617 cites W2944759755 @default.
• W4296396617 cites W2998989384 @default.
• W4296396617 cites W3008798432 @default.
• W4296396617 cites W3014737058 @default.
• W4296396617 cites W3080759371 @default.
• W4296396617 cites W3083376980 @default.
• W4296396617 cites W3106495943 @default.
• W4296396617 cites W3126722336 @default.
• W4296396617 cites W3136593283 @default.
• W4296396617 cites W3177135539 @default.
• W4296396617 cites W3188313116 @default.
• W4296396617 cites W3193495508 @default.
• W4296396617 cites W3194492589 @default.
• W4296396617 cites W3200183519 @default.
• W4296396617 cites W4221137153 @default.
• W4296396617 cites W4254323572 @default.
• W4296396617 doi "https://doi.org/10.3389/fonc.2022.951662" @default.
• W4296396617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36203425" @default.
• W4296396617 hasPublicationYear "2022" @default.
• W4296396617 type Work @default.
• W4296396617 citedByCount "3" @default.
• W4296396617 countsByYear W42963966172023 @default.
• W4296396617 crossrefType "journal-article" @default.
• W4296396617 hasAuthorship W4296396617A5015691544 @default.
• W4296396617 hasAuthorship W4296396617A5025699073 @default.
• W4296396617 hasAuthorship W4296396617A5026173634 @default.
• W4296396617 hasAuthorship W4296396617A5026368285 @default.
• W4296396617 hasAuthorship W4296396617A5038197610 @default.
• W4296396617 hasAuthorship W4296396617A5040733348 @default.
• W4296396617 hasAuthorship W4296396617A5041857612 @default.
• W4296396617 hasAuthorship W4296396617A5046606681 @default.
• W4296396617 hasAuthorship W4296396617A5050982520 @default.
• W4296396617 hasAuthorship W4296396617A5052470134 @default.
• W4296396617 hasAuthorship W4296396617A5054961792 @default.
• W4296396617 hasAuthorship W4296396617A5056415273 @default.
• W4296396617 hasAuthorship W4296396617A5056603443 @default.
• W4296396617 hasAuthorship W4296396617A5057389049 @default.
• W4296396617 hasAuthorship W4296396617A5059661948 @default.
• W4296396617 hasAuthorship W4296396617A5064240367 @default.
• W4296396617 hasAuthorship W4296396617A5066790760 @default.
• W4296396617 hasAuthorship W4296396617A5068946724 @default.
• W4296396617 hasAuthorship W4296396617A5074341433 @default.
• W4296396617 hasAuthorship W4296396617A5076500054 @default.
• W4296396617 hasAuthorship W4296396617A5077643980 @default.
• W4296396617 hasAuthorship W4296396617A5081959980 @default.
• W4296396617 hasAuthorship W4296396617A5082347133 @default.
• W4296396617 hasAuthorship W4296396617A5085501918 @default.
• W4296396617 hasAuthorship W4296396617A5088700252 @default.

• next